Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chorioallantoic Membrane | 2 | 2024 | 12 | 0.960 |
Why?
|
| Chickens | 1 | 2022 | 302 | 0.710 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2018 | 75 | 0.560 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2015 | 5 | 0.480 |
Why?
|
| Biomarkers, Tumor | 3 | 2025 | 1679 | 0.470 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2015 | 304 | 0.470 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 741 | 0.460 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 682 | 0.450 |
Why?
|
| Mammary Glands, Animal | 2 | 2015 | 455 | 0.440 |
Why?
|
| Epithelial Cells | 2 | 2015 | 906 | 0.410 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2025 | 541 | 0.380 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 2681 | 0.320 |
Why?
|
| Cell Proliferation | 2 | 2015 | 2511 | 0.290 |
Why?
|
| Chick Embryo | 2 | 2024 | 120 | 0.240 |
Why?
|
| Signal Transduction | 3 | 2025 | 4720 | 0.230 |
Why?
|
| Heterografts | 2 | 2022 | 199 | 0.220 |
Why?
|
| Neoplasm Invasiveness | 3 | 2025 | 665 | 0.210 |
Why?
|
| Proteogenomics | 1 | 2025 | 110 | 0.210 |
Why?
|
| Anoctamin-1 | 1 | 2022 | 3 | 0.190 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 4690 | 0.180 |
Why?
|
| Receptor, ErbB-2 | 1 | 2024 | 549 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 816 | 0.170 |
Why?
|
| Cisplatin | 1 | 2022 | 282 | 0.170 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 440 | 0.160 |
Why?
|
| Aldehyde Oxidase | 1 | 2019 | 7 | 0.160 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2019 | 67 | 0.150 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2019 | 26 | 0.150 |
Why?
|
| Mice | 7 | 2024 | 18504 | 0.140 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 106 | 0.140 |
Why?
|
| Smoothened Receptor | 2 | 2015 | 34 | 0.140 |
Why?
|
| Animals | 8 | 2024 | 34842 | 0.140 |
Why?
|
| Urinary Bladder | 1 | 2019 | 255 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2022 | 700 | 0.140 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2024 | 899 | 0.130 |
Why?
|
| Breast | 1 | 2018 | 217 | 0.130 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 265 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2019 | 356 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 623 | 0.120 |
Why?
|
| Progesterone | 1 | 2018 | 451 | 0.120 |
Why?
|
| Estrogens | 1 | 2018 | 436 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 2313 | 0.120 |
Why?
|
| Disease Progression | 2 | 2019 | 2230 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2024 | 998 | 0.110 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 1161 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2015 | 2449 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1829 | 0.090 |
Why?
|
| Drosophila | 1 | 2015 | 824 | 0.080 |
Why?
|
| Paracrine Communication | 1 | 2011 | 70 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 3691 | 0.080 |
Why?
|
| Humans | 9 | 2025 | 132201 | 0.080 |
Why?
|
| Female | 7 | 2025 | 70754 | 0.070 |
Why?
|
| Estriol | 1 | 2005 | 9 | 0.060 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2005 | 17 | 0.060 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2025 | 81 | 0.060 |
Why?
|
| Phenols | 1 | 2005 | 57 | 0.060 |
Why?
|
| Steroids | 1 | 2005 | 174 | 0.050 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2005 | 138 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2025 | 234 | 0.050 |
Why?
|
| Risk Factors | 1 | 2018 | 10944 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2011 | 1964 | 0.050 |
Why?
|
| Estradiol | 1 | 2005 | 488 | 0.050 |
Why?
|
| Chloride Channels | 1 | 2022 | 63 | 0.050 |
Why?
|
| RNA Editing | 1 | 2001 | 36 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2001 | 140 | 0.040 |
Why?
|
| Proteomics | 1 | 2025 | 596 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2001 | 183 | 0.040 |
Why?
|
| Lysosomes | 1 | 2022 | 261 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2019 | 41 | 0.040 |
Why?
|
| NADP | 1 | 2019 | 54 | 0.040 |
Why?
|
| Kynurenine | 1 | 2019 | 26 | 0.040 |
Why?
|
| Zebrafish | 1 | 2022 | 418 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 94 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 140 | 0.040 |
Why?
|
| Nucleotides | 1 | 2019 | 89 | 0.040 |
Why?
|
| Swine | 1 | 2022 | 1179 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 398 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 302 | 0.040 |
Why?
|
| Liver | 1 | 2005 | 1797 | 0.030 |
Why?
|
| Cell Line | 1 | 2022 | 2724 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2001 | 607 | 0.030 |
Why?
|
| Metabolome | 1 | 2019 | 324 | 0.030 |
Why?
|
| Rats | 1 | 2022 | 3607 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 1757 | 0.030 |
Why?
|
| Metabolomics | 1 | 2019 | 479 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2001 | 2679 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 1363 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2011 | 679 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 755 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 2196 | 0.030 |
Why?
|
| Transcriptome | 1 | 2019 | 1125 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 2062 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2011 | 196 | 0.020 |
Why?
|
| Cell Communication | 1 | 2011 | 186 | 0.020 |
Why?
|
| Integrases | 1 | 2011 | 159 | 0.020 |
Why?
|
| Collagen | 1 | 2011 | 303 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2011 | 263 | 0.020 |
Why?
|
| Neoplasms | 1 | 2024 | 2961 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2011 | 212 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1382 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 21456 | 0.020 |
Why?
|
| Male | 2 | 2025 | 64979 | 0.020 |
Why?
|
| Macrophages | 1 | 2011 | 692 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 308 | 0.010 |
Why?
|
| Middle Aged | 1 | 2025 | 29007 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 1080 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 1285 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 1045 | 0.010 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2001 | 11 | 0.010 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2001 | 24 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2001 | 90 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2001 | 158 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 165 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 4538 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2001 | 173 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 275 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 651 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 811 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2001 | 395 | 0.010 |
Why?
|
| Testosterone | 1 | 2005 | 611 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 760 | 0.010 |
Why?
|
| Lung | 1 | 2005 | 1556 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 2669 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 3771 | 0.010 |
Why?
|